TBC1D15 Activators
TBC1D15 Activators belong to a unique chemical class that plays a crucial role in regulating cellular processes, particularly those associated with intracellular trafficking and vesicle transport. TBC1D15, short for TBC1 Domain Family Member 15, is a protein encoded by the TBC1D15 gene. It acts as a key modulator in the intricate machinery of cellular logistics. TBC1D15 itself contains a TBC (Tre-2/Bub2/Cdc16) domain, a conserved protein domain often found in proteins involved in the regulation of small GTPases. In this case, TBC1D15 serves as a GTPase-activating protein (GAP) for Rab7, a member of the Ras superfamily of GTPases.
TBC1D15 Activators are a group of chemical compounds or molecules that have been identified for their ability to enhance the GAP activity of TBC1D15. This means that they facilitate the conversion of active GTP-bound Rab7 into its inactive GDP-bound form more efficiently. By doing so, TBC1D15 Activators help regulate the dynamics of endosomal and lysosomal trafficking within the cell. This process is essential for maintaining proper cellular homeostasis, including the degradation of cellular waste and the recycling of membrane proteins. While the specific mechanisms of TBC1D15 activation by these compounds may vary, their overarching function is to fine-tune the molecular switches that govern vesicular transport, which has broad implications for cellular processes such as autophagy, endocytosis, and the sorting of cargo molecules.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin and its analogs activate the insulin receptor, initiating downstream signaling cascades that indirectly influence glucose transport and related pathways, potentially increasing TBC1D15. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an AMPK activator. AMPK activation can influence energy-related processes, potentially affecting autophagy and metabolic pathways, which may have positive downstream effects on TBC1D15-mediated processes. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Metformin is an AMPK activator. Similar to AICAR, it can indirectly affect cellular pathways, including autophagy and metabolic processes, which may have positive downstream effects on TBC1D15-regulated pathways. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a dynamin inhibitor that interferes with vesicle scission during endocytosis. By inhibiting dynamin, dynasore can indirectly impact endocytic processes and vesicle trafficking pathways, potentially activating TBC1D15-regulated processes. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits vacuolar ATPase, affecting endosomal acidification. This indirectly influences the maturation of endosomes and lysosomes, which may impact vesicle trafficking pathways that activate TBC1D15-regulated processes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine also affects endosomal acidification. Similar to bafilomycin A1, it can indirectly influence the maturation of endosomes and lysosomes, potentially impacting vesicle trafficking pathways increasing TBC1D15. | ||||||